DaVita Inc (FRA:TRL)
€ 134.4 0.7 (0.55%) Market Cap: 10.93 Bil Enterprise Value: 21.15 Bil PE Ratio: 15.64 PB Ratio: 30.97 GF Score: 82/100

DaVita Inc 2021 Capital Markets Day Transcript

Nov 16, 2021 / 03:00PM GMT
Release Date Price: €93.14 (+1.44%)
Jim Gustafson
DaVita Inc. - VP of IR

Hello, I'm Jim Gustafson, DaVita's Vice President of Investor Relations, and I'd like to welcome everyone to DaVita's 2021 Virtual Capital Markets Day.

We appreciate your interest in the company. This presentation is available on our website at investors.davita.com and will also be available for replay on the same website. Today, you will hear from our Chief Executive Officer, Javier Rodriguez; and our Chief Financial Officer, Joel Ackerman. We're excited to have the opportunity to update you on the current status of our business and the progress we have made in executing against the strategy that we laid out in our 2019 Capital Markets Day. We'll also go into greater detail on a few topics of investor interest, including the growth of our Integrated Kidney Care platform. We will share a multiyear financial outlook, and we'll leave plenty of time at the end to take your questions.

Please note that during today's presentation and Q&A, we expect to discuss some non-GAAP financial measures. A reconciliation of these non-GAAP measures to the most

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot